HomePolitics

From California To Cuba: The Dangerous Revival Of Government-Run Medicine

Across Democratic politics in 2026, the old single-payer fantasy is back in fashion. From Bernie Sanders’ long-running Medicare for All crusade to California Democrats again treating government-run health care as an article of faith, the political left is once again promising that centralized control can solve the nation’s health care problems.

That revival matters because it is not just rhetorical. California Democrats’ platform continues to endorse a publicly funded single-payer system, despite years of political and fiscal failure to make it work in the nation’s largest state. Candidates for governor are once again being pushed to embrace the idea, even though California’s prior single-payer efforts ran into enormous cost estimates, political resistance, and basic questions about how the state would finance and deliver such a system. In other words, the theory remains popular, but the reality remains untested and unaffordable.

At the same time, Congresswoman Pramila Jayapal’s recent praise of Cuba’s health care system should alarm anyone who still believes the single-payer argument is grounded in patient outcomes rather than ideology. Her claim that Cuba offers a superior model is not just controversial; it is revealing. Socialized systems may promise universality, but they typically deliver rationing, shortages, delays, and reduced patient choice. And when advocates hold up Cuba as an example, they are not defending a higher-performing model of care. They are defending state control over medicine itself.

That is the central flaw of single-payer and socialized systems: they replace competition and innovation with bureaucracy and political allocation. Once government becomes the sole payer, it also becomes the chief decider of what gets covered, when care is delivered, and how much providers are paid. That inevitably creates pressure on access. Doctors, hospitals, and drugmakers face lower reimbursements, longer administrative delays, and fewer incentives to invest in new services or technologies. Patients may be told they have coverage, but coverage means little if care is delayed or unavailable.

The fiscal problem is no less serious. Single-payer plans promise broad benefits, but they do so by assuming the government can absorb massive new costs without harming taxpayers, providers, or innovation. California’s own debates have repeatedly run into that wall, with estimates showing staggering annual costs and unanswered questions about what taxes would rise to pay for them. That is why the idea keeps returning as a slogan and never arriving as a workable system.

The experience of socialized systems abroad only reinforces the point. Nations that heavily centralize payment and price-setting often gain predictability, but they sacrifice flexibility, speed, and responsiveness. Patients may face restricted formularies, fewer treatment options, and longer waits for specialty care. What sounds efficient on paper often becomes a bottleneck in practice.

That is why the renewed enthusiasm for Medicare for All is so misguided. Supporters frame it as a moral imperative, but there is nothing moral about a system that promises everything and then struggles to deliver enough. Nor is it progressive to import a model that weakens incentives for medical innovation, lowers access for private patients, and places even more control in the hands of distant bureaucracies. Health care works best when patients and doctors have more choice, not less.

Jayapal’s Cuba comments only sharpen the contrast. Cuba is not a blueprint for American reform; it is a warning. A government may claim success by pointing to universal coverage, but if the system depends on shortages, rationing, low wages, and political control, then universality becomes a veneer over decline. That is not the future Americans should want.

Democrats in Washington and California may be reviving the single-payer message for political purposes, but voters should see it for what it is: a promise of affordability built on reduced choice, lower quality, and heavier government control. The better path is not to copy Cuba or double down on Medicare for All. It is to strengthen competition, protect access, and keep innovation alive in a health care system that still, despite its flaws, delivers more of the world’s most advanced care than any government-run model ever has.

About The Author: Mike Essen — Long-time Talk Radio Host and Podcaster of Conservative Thought and Principles. The Mike Essen Show- Retired   

Please make a small donation to the Tampa Free Press to help sustain independent journalism. Your contribution enables us to continue delivering high-quality, local, and national news coverage.

Sign up: Subscribe to our free newsletter for a curated selection of top stories delivered straight to your inbox